The bill aims to ensure all users, especially adolescents, are aware of the potential mental health risks posed by social ...

Q3 2025 Management View CEO Pravin Dugel described 2025 as "a transformative year for Ocular Therapeutix" and highlighted the advancement of two registrational studies in wet AMD, SOL-1 and SOL-R.

Salesforce’s Sunya Norman tells Newsweek how the company is leveraging its decades-long AI experience to solve today's ...

The fate of the enhanced Affordable Care Act premium tax credits — initially bolstered during the pandemic — is still unclear ...

The government extended the consultation deadline for AI content labeling rules to November 13, addressing industry concerns over operational burdens.

The HHS has announced changes to estrogen hormone therapy black box labeling for menopause treatment in a move that they said corrects misleading warnings.HHS Secretary Robert F. Kennedy Jr. said in a ...

A Pending Crisis" will be a public forum presented by Tulare County Voices at 210, at 7 p.m. on Tuesday, Nov. 11.

Open-label prophylaxis data supporting the long-term safety profile and sustained benefits of deucrictibant, as well as clinical validation data ...

Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address mast cell ...

New review of research shows benefits outweigh risks for women who start treatment within 10 years of menopause onset After [ ...

Capricor Therapeutics, Inc. ( CAPR) Q3 2025 Earnings Call November 10, 2025 4:30 PM EST Good afternoon, ladies and gentlemen, and welcome to the Capricor Therapeutics Third Quarter 2025 Conference ...

Q3 2025 Earnings Call November 10, 2025 5:00 PM ESTCompany ParticipantsRick Winningham - CEO & DirectorRhonda Farnum ...